12/2016. CLUSTOID / CLUSTEK – Safety study

A study of 1,855 patients (1,156 adults and 699 children) who have been treated with Clustoid / Clustek (INMUNOTEK), including the most allergenic concentrations (Max and Forte), has been published online in the journal Allergologia et Immunopathologia.

In this study, the number and type of reactions produced after the administration of each dose (11,753 injections in total) were evaluated. The results confirm the excellent safety profile of these preparations in rapid build-up protocols, both in adults and children. Most of the reactions have been local and expected (allergic in nature).